US2017037029A1PendingUtilityA1
Endoparasite control agent
Est. expiryAug 30, 2032(~6.1 yrs left)· nominal 20-yr term from priority
A61P 33/10A61P 33/02A61P 33/00A61K 31/39C07D 277/56C07D 231/14A61K 31/44A61K 31/426C07D 401/00C07D 327/06A61K 31/4965A61K 31/4439C07D 239/28A61K 31/497A61K 31/427A61K 31/381A61K 31/505C07D 241/24A61K 31/415A61K 31/444C07D 333/38A61K 31/4155C07D 307/68C07D 401/12A61K 31/506A61K 31/341C07D 213/82A61K 31/4436A61K 31/443
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An object of the present invention is to provide a novel endoparasite control agent as a parasiticide, an antiprotozoal or the like. Provided is an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): (wherein Het represents a 5- or 6-membered heterocyclic group), or a salt thereof as an active ingredient.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A method for controlling endoparasites, comprising orally or parenterally administering an effective amount of an endoparasite control composition comprising a compound of the general formula (I):
wherein
is any moiety selected from the group consisting of the following Het1 to Het3 and Het8 to Het17:
wherein
the numbers on each ring represent positions where the ring can be substituted by X and the free bond extending from each ring is a bond between Het and the carbonyl group in the general formula (I),
each X can be the same or different, and represents a halogen atom; a cyano group; a nitro group; an amino group; a (C 1 -C 6 ) alkyl group; a halo (C 1 -C 6 ) alkyl group; a (C 1 -C 6 ) alkoxy group; a halo (C 1 -C 6 ) alkoxy group; a halo (C 1 -C 6 ) alkylthio group; a (C 1 -C 6 ) alkylsulfinyl group; a halo (C 1 -C 6 ) alkylsulfinyl group; a (C 1 -C 6 ) alkylsulfonyl group; or a halo (C 1 -C 6 ) alkylsulfonyl group,
X 1 represents a halogen atom, a (C 1 -C 6 ) alkyl group; or a halo (C 1 -C 6 ) alkyl group,
m represents an integer of 0 to 5,
A represents a (C 1 -C 8 ) alkylene group; or a substituted (C 1 -C 8 ) alkylene group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group and a (C 3 -C 6 ) cycloalkyl group, with the proviso that the (C 1 -C 8 ) alkylene group and the substituted (C 1 -C 8 ) alkylene group can be modified by incorporation, into the carbon chain, of at least one group selected from —O—, —S—, —SO—, —SO 2 — and —N(R)—, wherein R represents a hydrogen atom, a (C 1 -C 6 ) alkyl group, a (C 3 -C 6 ) cycloalkyl group, a (C 1 -C 6 ) alkylcarbonyl group or a (C 1 -C 6 ) alkoxycarbonyl group, and with the proviso that when the alkylene group or the substituted alkylene group having one or more substituents is a (C 3 -C 6 ) or (C 3 -C 8 ) alkylene group, or a (C 2 -C 6 ) or (C 2 -C 8 ) alkylene group modified by incorporation, into the carbon chain, of at least one group selected from —O—, —S—, —SO—, —SO 2 — and —N(R)—, A can form a cyclic structure that is cyclopropane, cyclobutane, cyclopentane or cyclohexane,
E represents a hydrogen atom; a (C 1 -C 6 ) alkyl group; a (C 3 -C 6 ) cycloalkyl group; a (C 1 -C 6 ) alkoxy (C 1 -C 6 ) alkyl group; a (C 1 -C 6 ) alkylcarbonyl group; or a (C 1 -C 6 ) alkoxycarbonyl group, and
B represents any of the moieties represented by the following B1 to B8:
wherein each Y can be the same or different, and represents a halogen atom; a cyano group; a nitro group; a hydroxy group; a (C 1 -C 6 ) alkyl group; a halo (C 1 -C 6 ) alkyl group; a (C 2 -C 6 ) alkenyl group; a halo (C 2 -C 6 ) alkenyl group; a (C 2 -C 6 ) alkynyl group; a halo (C 2 -C 6 ) alkynyl group; a (C 1 -C 6 ) alkoxy group; a halo (C 1 -C 6 ) alkoxy group; a (C 1 -C 6 ) alkoxy (C 1 -C 6 ) alkoxy group; a (C 2 -C 6 ) alkenyloxy group; a halo (C 2 -C 6 ) alkenyloxy group; a (C 2 -C 6 ) alkynyloxy group; a halo (C 2 -C 6 ) alkynyloxy group; a (C 1 -C 6 ) alkylthio group; a halo (C 1 -C 6 ) alkylthio group; a (C 1 -C 6 ) alkylsulfinyl group; a halo (C 1 -C 6 ) alkylsulfinyl group; a (C 1 -C 6 ) alkylsulfonyl group; a halo (C 1 -C 6 ) alkylsulfonyl group; a (C 1 -C 6 ) alkoxycarbonyl group; a (C 1 -C 6 ) alkoxyimino (C 1 -C 3 ) alkyl group; a (C 3 -C 30 ) trialkylsilyl group; a mono (C 1 -C 6 ) alkylsulfonylamino group; a mono halo (C 1 -C 6 ) alkylsulfonylamino group; a phenyl group; a substituted phenyl group having one or more substituents selected from group Z substituents on the ring; a phenoxy group; a substituted phenoxy group having one or more substituents selected from group Z substituents on the ring; a heterocyclic group; a substituted heterocyclic group having one or more substituents selected from group Z substituents on the ring; a heterocycloxy group; or a substituted heterocycloxy group having one or more substituents selected from group Z substituents on the ring,
the group Z substituents are a halogen atom; a cyano group; a nitro group; a (C 1 -C 6 ) alkyl group; a halo (C 1 -C 6 ) alkyl group; a (C 2 -C 6 ) alkenyl group; a halo (C 2 -C 6 ) alkenyl group; a (C 2 -C 6 ) alkynyl group; a halo (C 2 -C 6 ) alkynyl group; a (C 1 -C 6 ) alkoxy group; a halo (C 1 -C 6 ) alkoxy group; a (C 2 -C 6 ) alkenyloxy group; a halo (C 2 -C 6 ) alkenyloxy group; a (C 2 -C 6 ) alkynyloxy group; a halo (C 2 -C 6 ) alkynyloxy group; a (C 1 -C 6 ) alkylthio group; a halo (C 1 -C 6 ) alkylthio group; a (C 1 -C 6 ) alkylsulfinyl group; a halo (C 1 -C 6 ) alkylsulfinyl group; a (C 1 -C 6 ) alkylsulfonyl group; a halo (C 1 -C 6 ) alkylsulfonyl group; a (C 1 -C 6 ) alkoxycarbonyl group; and a (C 1 -C 6 ) alkoxyimino (C 1 -C 3 ) alkyl group,
Y 1 represents a (C 1 -C 6 ) alkyl group,
n represents an integer of 0 to 5, with the proviso that when n is an integer of 2 to 5, two adjacent Y groups can join together to form a (C 3 -0 5 ) alkylene group; a (C 3 -0 5 ) alkenylene group; a (C 2 -C 4 ) alkyleneoxy group; a (C 1 -C 3 ) alkylene dioxy group; or a halo (C 1 -C 3 ) alkylene dioxy group, and
the numbers on each ring represent positions where the ring can be substituted by Y and the free bond extending from each ring is a bond between A and B, or
a salt thereof as an active ingredient to a non-human mammal or a bird, wherein the endoparasite is helminths.
12 . The method according to claim 11 , wherein the effective amount of the endoparasite control agent is orally or parenterally administered to a non-human mammal.
13 . The method according to claim 12 , wherein the non-human mammal is a domestic animal.
14 . The method according to claim 11 , wherein
is selected from the group consisting of Het8 to Het17.
15 . The method according to claim 11 , wherein A is a (C 1 -C 8 ) alkylene group; or a substituted (C 1 -C 8 ) alkylene group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group and a (C 3 -C 6 ) cycloalkyl group.
16 . The endoparasite control agent method according to claim 11 , wherein B is selected from the group consisting of B5 to B8.
17 . The method according to claim 14 ,
wherein
is selected from the group consisting of Het8 to Het14,
each X can be the same or different, and is a halogen atom; a (C 1 -C 6 ) alkyl group; or a halo (C 1 -C 6 ) alkyl group,
m is 1 or 2,
A is a (C 1 -C 8 ) alkylene group; or a (C 1 -C 8 ) alkylene group substituted by a (C 1 -C 6 ) alkyl group,
E is a hydrogen atom,
B is B1, B2 or B5,
each Y can be the same or different, and is a halogen atom; a (C 1 -C 6 ) alkyl group; a halo (C 1 -C 6 ) alkyl group; a phenyl group; a substituted phenyl group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group and a halo (C 1 -C 6 ) alkoxy group on the ring; a phenoxy group; a substituted phenoxy group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group and a halo (C 1 -C 6 ) alkoxy group on the ring; a pyridyl group; a substituted pyridyl group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group and a halo (C 1 -C 6 ) alkoxy group on the ring; a pyridyloxy group; or a substituted pyridyloxy group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group and a halo (C 1 -C 6 ) alkoxy group on the ring, and n is an integer of 1 to 3.
18 . The method according to claim 14 ,
wherein
is Het1, Het2, Het14, Het15 or Het17,
each X can be the same or different, and is a halogen atom; a (C 1 -C 6 ) alkyl group; or a halo (C 1 -C 6 ) alkyl group,
m is 1 or 2,
A is a (C 1 -C 8 ) alkylene group; or a (C 1 -C 8 ) alkylene group substituted by a (C 1 -C 6 ) alkyl group,
E is a hydrogen atom,
B is B1,
each Y can be the same or different, and is a halogen atom; a (C 1 -C 6 ) alkyl group; a halo (C 1 -C 6 ) alkyl group; a phenyl group; a substituted phenyl group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group and a halo (C 1 -C 6 ) alkoxy group on the ring; a phenoxy group; a substituted phenoxy group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group and a halo (C 1 -C 6 ) alkoxy group on the ring; a pyridyl group; a substituted pyridyl group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group and a halo (C 1 -C 6 ) alkoxy group on the ring; a pyridyloxy group; or a substituted pyridyloxy group having one or more substituents selected from a halogen atom, a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group and a halo (C 1 -C 6 ) alkoxy group on the ring, and
n is an integer of 1 to 3.Join the waitlist — get patent alerts
Track US2017037029A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.